Meaning
Biological evaluation technique used to detect the presence of endocrine-active chemicals or other bioactive contaminants in plastic food packaging and medical devices. Routine bioassay screening detects both known and unknown migrating species that chemical analyses might overlook. This procedure tests the combined effects of all extractable substances instead of measuring individual chemicals.
Target Mechanism
Cellular models with specific hormone receptors are exposed to polymer extracts to measure response. This bioassay screening uses engineered cell lines that express a light-producing protein when activated by specific compounds. The luminescence indicates the concentration of hazardous chemicals.
Processing Link
High melt temperatures during the injection molding process sometimes create new breakdown products from harmless additives. Utilizing bioassay screening helps compounders identify the thermal conditions that cause these toxic degradation products to form. This test prevents unsafe materials from entering the medical supply chain.
Material Selection
Choosing alternative resin formulations depends on proving the lack of biological activity in the final molded article. This bioassay screening offers a clear pass or fail threshold that guides the selection of stabilizers and antioxidants for sensitive polymer applications, protecting the final user from exposure to harmful hormone mimics that could leach from the finished parts during high-temperature sterilization processes.